BridgeBio have demonstrably improved its progress of the novel therapy for ATTR-CM, utilizing the compound. Early trial data indicates potential benefits for those suffering with this serious condition. This focus highlights researchers’ focus to addressing unmet healthcare requirements in this cardiology space. Attruby: BridgeBio's Novel Approa